GHENT, Belgium -— Llama antibodies could soon be playing a role in the global fight against COVID-19, if clinical trials being conducted by a Belgian biomedical start-up live up to their early promise. Researchers from the VIB-UGent Center for Medical Biotechnology in Ghent say antibodies extracted from a llama called
